Stifel Financial’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$46.9M Sell
97,165
-36,451
-27% -$9.67M 0.04% 401
2026
Q1
$14.6M Buy
133,616
+29,156
+28% +$4.15M 0.01% 764
2025
Q4
$17.4M Buy
104,460
+13,110
+14% +$2.19M 0.02% 692
2025
Q3
$17.9M Sell
91,350
-23,801
-21% -$3.91M 0.02% 675
2025
Q2
$10.4M Buy
115,151
+22,494
+24% +$1.78M 0.01% 862
2025
Q1
$5.53M Buy
92,657
+46,917
+103% +$4.34M 0.01% 1136
2024
Q4
$6.06M Sell
45,740
-52,721
-54% -$4.95M 0.01% 1100
2024
Q3
$5.16M Buy
98,461
+57,638
+141% +$2.71M 0.01% 1184
2024
Q2
$2.47M Buy
40,823
+37,613
+1,172% +$2.61M ﹤0.01% 1579
2024
Q1
$238K Buy
+3,210
New +$238K ﹤0.01% 3025

Other funds holding ALAB

Stifel Financial's ALAB Position: Q2 2026 in Review

Stifel Financial reduced its Astera Labs (ALAB) stake by 27% in Q2 2026, selling an estimated $9.67M and leaving 97,165 shares worth $46.9M. The position accounts for 0.04% of the portfolio, ranked #401.

Stifel Financial first reported a position in ALAB in Q1 2024 and has held it in 10 quarters since. 988 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Stifel Financial held 97,165 shares of Astera Labs worth $46.9M as of Q2 2026.
  • Stifel Financial sold 36,451 Astera Labs shares in Q2 2026, an estimated $9.67M.
  • Astera Labs made up 0.04% of Stifel Financial's portfolio in Q2 2026, its #401 holding.
  • Stifel Financial first reported a position in Astera Labs in Q1 2024 and has held it in 10 quarters since.
  • 988 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.